Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The provisional extracellular matrix (pECM) is a transient, specialized environment formed immediately following tissue injury, primarily through the polymerization of fibrinogen and the incorporation of plasma fibronectin (StatPearls, 2023). It serves as the initial structural scaffold that stabilizes the wound and provides a substrate for the migration of neutrophils, macrophages, fibroblasts, and endothelial cells (Journal of Cell Science, 2010). In addition to its mechanical properties, the pECM functions as a dynamic signaling hub by sequestering growth factors and presenting ligands for cell-surface integrins, thereby orchestrating the transition from inflammation to tissue repair (Nature Reviews Molecular Cell Biology, 2014). Dysregulation of pECM formation or degradation is a hallmark of chronic non-healing wounds and fibroproliferative disorders, where the matrix may become persistent or excessively dense (Advanced Drug Delivery Reviews, 2018). Therapeutic interventions often target the pECM by providing synthetic or biological substitutes, modulating matrix-degrading enzymes, or utilizing the matrix as a delivery vehicle for regenerative proteins (PubMed, 2021). This matrix is also increasingly recognized for its role in the tumor microenvironment, where it supports cancer cell invasion and immune evasion (Cancer Research, 2019).
The provisional extracellular matrix acts as a temporary physical scaffold for cellular infiltration and a reservoir for growth factors, facilitating tissue regeneration through integrin-mediated signaling and mechanical stabilization of the wound site (StatPearls, 2023; Nature Reviews Molecular Cell Biology, 2014).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Provisional extracellular matrix (pECM).